What is Tiziana Life Sciences Ltd's share price today?
Tiziana Life Sciences Ltd (TLSA) share price today is $1.05 as of October 17, 2026 at 1:30 AM IST. The stock touched a day high of $1.11 and a day low of $1.04.What exchange does Tiziana Life Sciences Ltd stock trade on, and under what ticker symbol?
Tiziana Life Sciences Ltd stock trades on NASDAQ under the ticker symbol TLSA.What is Tiziana Life Sciences Ltd's market capitalization?
Tiziana Life Sciences Ltd's market capitalization is $133.62M as of October 17, 2026 at 1:30 AM IST.What is Tiziana Life Sciences Ltd's price-to-earnings (P/E) ratio?
Tiziana Life Sciences Ltd's price-to-earnings (P/E) ratio is N/A as of October 18, 2026.What is Tiziana Life Sciences Ltd's price-to-book (P/B) ratio?
Tiziana Life Sciences Ltd's price-to-book (P/B) ratio is 2569.65 as of October 18, 2026.Can Indian investors buy Tiziana Life Sciences Ltd shares?
Yes, You can buy Tiziana Life Sciences Ltd shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Tiziana Life Sciences Ltd shares from India?
Indian investors can buy Tiziana Life Sciences Ltd shares in three steps: 1. Search Tiziana Life Sciences Ltd on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Tiziana Life Sciences Ltd shares for Indian investors?
Since Tiziana Life Sciences Ltd trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Tiziana Life Sciences Ltd shares via Tickertape?
Indian investors can start investing in Tiziana Life Sciences Ltd (TLSA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 9.4786 shares at the current price of $1.05.
$
₹
$1.050.47% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
2569.65
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-0.15
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 2 analysts reports
Buy2 analysts
Hold0 analyst
Sell0 analyst
Price Upside
+662.55%
Earnings Growth
—
Rev. Growth
—
Company Profile
Company Profile
ABBV
P/E Ratio
77.45
77.45
1Y Return
24.91%
24.91%
Buy Reco %
80.00
80.00
AMGN
P/E Ratio
25.63
25.63
1Y Return
47.24%
47.24%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
32.53%
32.53%
Buy Reco %
78.57
78.57
P/E Ratio
28.86
28.86
1Y Return
22.3%
22.3%
Buy Reco %
81.25
81.25
MRNA
P/E Ratio
—
—
1Y Return
703.27%
703.27%
Buy Reco %
21.73
21.73
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$1.05Baseline
Analyst Target - 1 year
Target$8.01+662.55%
All values in $
2026
Current$1.05Baseline
Analyst Target - 1 year
Target$8.01+662.55%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Revenue
Net Income
| Financial Year | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -0.04 | -0.04 | -0.12 | -0.12 | - | -0.06 | -0.08 | -0.08 | - | -0.14 |
| Net Income | -9.07 | -9.07 | -9.30 | -9.30 | - | -7.20 | -5.63 | -5.63 | - | -12.79 |
| Net Profit Margin | - | - | - | - | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareBiotechnology
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Tiziana Life Sciences Ltd | - | 2569.65 | - |
| AbbVie Inc | 77.45 | 50.45 | 0.54 |
| Amgen Inc | 25.63 | 18.78 | 2.45 |
Price Comparison
Price Comparison
Compare TLSA with any stock or ETFCompare TLSA with any stock or ETF
Comparing from
TLSA
ABBV
AMGN
The 12-month consensus target implies 662.55% growth, versus a trailing 3-year CAGR of 7.30%.